Vaccine can effectively inhibit virus replication, causes 99% reduction of virus quantity in hamsters
By: Sophia Yang, Taiwan News, Staff Writer
Taiwan's National Health Research Institutes (NHRI) announced on Monday (Aug. 10) that it has made progress on a gene-based vaccine co-developed with the Taichung-based biotech company Enimmune. Animal tests have shown that the amount of coronavirus in the lungs of infected hamsters inoculated with the candidate vaccine, developed through genetic engineering, is far smaller than in those uninoculated.
The uninoculated hamsters experienced a loss of weight and vitality. The inoculated hamsters did not.
Virus replication was effectively inhibited among the inoculated hamsters, which resulted in a 99 percent reduction of the amount of virus in the creatures, indicating that the vaccine offers excellent protection. In a signal that the vaccine is fairly safe, a high level of T helper type 1 cells (Th1) were generated among the inoculated hamsters as well. [FULL STORY]